Download our latest Foresight article

The challenges of clinical trial recruitment are well-known to drug developers. Yet while difficulties on the macro level are well-recognized, it is the micro-level details that ultimately determine the success or failure of enrollment efforts in each clinical trial.

• Is the protocol sufficiently attractive to doctors and patients?
• In what regions is the target disease incidence rising most rapidly?
• Where is the clinical trial burden relative to the size of the population most favorable?
• Will patients in those target regions be able to meet the inclusion criteria?

The answers to questions such as these are vital to create an accurate picture of how enrollment will progress in each individual trial. That’s where feasibility comes into play.

At INC Research, feasibility involves much more than just asking doctors how fast they’ll be able to bring patients into a trial. Our research has shown the increasing complexity of protocol designs can make it difficult for doctors to accurately predict how quickly they can enroll patients. That’s why we take a unique metrics-driven approach to feasibility based on what we call “the four pillars.”

Download our latest Foresight article to learn more about the combination of these proven feasibility strategies, as well as examples of how it has been critical to a trial.